Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
about
Why can't rodents vomit? A comparative behavioral, anatomical, and physiological studyThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinCannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and VomitingRegulation of nausea and vomiting by cannabinoids and the endocannabinoid systemA unique therapeutic approach to emesis and itch with a proanthocyanidin-rich genonutrient.Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlatesReceptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.Rearing on hind legs, environmental novelty, and the hippocampal formation.Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew.The antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrewReceptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting.Cannabinoid hyperemesis syndrome with extreme hydrophilia.
P2860
Q21090773-0C559E2D-B5A6-4FCA-BB68-2B63ED10BB53Q24643876-EE70F8AF-AB5A-4A50-88A4-DBD74B679EE7Q26738288-7DC779DB-FBBF-4C06-8039-11BABC918233Q28301264-DDB4FC75-5E57-4C72-ADC3-9AEFFE651820Q30443531-74D0FE38-C420-4D2B-8FA5-25C5871E8E08Q34278963-009EE986-6D3B-4B0B-84DB-ECF1A8667438Q34858094-5A1750E8-2ED9-4D50-B640-B1DCB784F313Q35164623-5306838B-77F2-484A-AD3C-89AA483906D3Q35942314-03697A07-D4CA-4301-A904-F801A1C7DA94Q36480368-C5FA0B2D-F270-4CA1-B126-FA77F906B489Q37036977-85CA6C30-B271-4B2F-B849-D4E2BE317391Q37101114-C7BFB605-720E-4D7E-A426-0370E4840069Q37407809-AA790D08-4193-4EE4-9FE1-4D6DD29D50E4Q38974456-6023CC25-0EB5-4672-BED0-833E903F69DBQ42090461-F82154D7-5ECF-4D42-90E4-53DA5E36ED80
P2860
Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Delta-9-tetrahydrocannabinol d ...... least shrew (Cryptotis parva).
@en
Delta-9-tetrahydrocannabinol d ...... or agonists in the least shrew
@nl
type
label
Delta-9-tetrahydrocannabinol d ...... least shrew (Cryptotis parva).
@en
Delta-9-tetrahydrocannabinol d ...... or agonists in the least shrew
@nl
prefLabel
Delta-9-tetrahydrocannabinol d ...... least shrew (Cryptotis parva).
@en
Delta-9-tetrahydrocannabinol d ...... or agonists in the least shrew
@nl
P921
P1476
Delta-9-tetrahydrocannabinol d ...... least shrew (Cryptotis parva).
@en
P2093
Jennifer L Crim
Nissar A Darmani
P356
10.1016/J.PBB.2004.10.019
P407
P577
2004-12-08T00:00:00Z